-
Venous thromboembolism (VTE) is the third most common cardiovascular condition behind myocardial infarction and stroke, with an incidence rate of about one per 1000 person-years.1,2 Nearly 5% of the population will experience
-
Polycystic ovarian syndrome patients with normospermic partners undergoing ovulation induction with letrozole had a higher live birth rate and no increase in adverse outcomes than women who received clomiphene citrate.
-
According to this pharmacokinetic study, the cyclic use of 20 mcg ethinyl estradiol oral contraceptives is problematic for obese women. Ovarian activity was better suppressed with continuous use (omitting the hormone-free interval) of the same dose oral contraceptive or increasing to a higher dose 30 mcg ethinyl estradiol oral contraceptive
-
A large prospective cohort study of perineal talc use demonstrated no increased risk of ovarian cancer overall or within any histological subtype. In addition, no association with talc application method was observed.
-
-
This study, done at a tertiary care university hospital here in the U.S., was initiated in an attempt to improve patient safety, conserve a vital resource, and reduce costs a laudable tripartite goal.
-
Each year when I lecture the incoming cardiology fellows on the management of non-ST elevation acute coronary syndromes (NSTE-ACS), we embark on a discussion of optimal guideline-driven treatment vs. real-world practicalities.
-
-
he Choosing Wisely Campaign was introduced in 2011 by the American Board of Internal Medicine to identify practices and procedures physicians and patients should question. The critical care top 5 list was developed through a collaborative effort of several critical care societies.
-
Patent foramen ovale (PFO) is common in both the general population, as well as in patients with cryptogenic stroke, with an estimated prevalence somewhere between 15-35%. Recurrent neurovascular events, both recurrent ischemic stroke as well as transient ischemic attacks, are frequent in these patients, but it is not clear whether patients with PFOs have an increased rate of recurrent events compared to those patients who do not have PFOs.
